La'Dale Robinson was living a full life as a single father, chef, and business owner when a routine checkup changed ...

Men of a certain age are essentially looking for either “a nurse or a purse,” according to 60-year-old Maryann, who's had six ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

An eminent oncologist, cancer researcher, and cancer center director is promoting a study that seems to show—but, when ...

Regarding disease-free survival, 88.6% of patients in the SBRT group were free from disease progression after three years, compared to 92.1% receiving longer courses of radiation. The difference was ...

On a recent Saturday near Seattle, Cheryl Ewaldsen pulled three golden loaves of wheat bread out of her kitchen oven.

Like Viagra, Stendra and Levitra, Cialis is highly effective as a treatment for ED. But no medication has a 100 percent success rate, and Cialis is … ...

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 ...

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of ...

At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...